Steven D. Targum, Christopher J. Catania 

Slides:



Advertisements
Similar presentations
The Good Fat Cell Volume 147, Issue 7, (December 2011) DOI: /j.cell Copyright © 2011 Terms and Conditions Terms and Conditions.
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Survey on computer aided decision support for diagnosis of celiac disease Sebastian Hegenbart, Andreas Uhl, Andreas Vécsei Computers in Biology and Medicine.
Treatment for Adolescents With Depression Study (TADS)
Shanna M. Guilfoyle, Sally Monahan, Cindy Wesolowski, Avani C. Modi
PATRICIA A. BRENNAN, PH. D. , ROBYNE LE BROCQUE, M. A
The association between the severity of poststroke depression and clinical outcomes after first-onset stroke in Korean patients  Geun-Young Park, M.D.,
Personalized Medicine in Psychiatry
Psychoeducational groups for adults with ADHD and their significant others (PEGASUS): A pragmatic multicenter and randomized controlled trial  T. Hirvikoski,
Psychoeducational groups for adults with ADHD and their significant others (PEGASUS): A pragmatic multicenter and randomized controlled trial  T. Hirvikoski,
S-adenosylmethionine (SAMe) and Magnesium Orotate as adjunctives to SSRIs in sub- optimal treatment response of depression in adults: A pilot study  Matthew.
Steven J. Linton, Alan E. Fruzzetti  Scandinavian Journal of Pain 
Efficacy of Cognitive-Behavioral Therapy for Insomnia Associated With Traumatic Brain Injury: A Single-Case Experimental Design  Marie-Christine Ouellet,
S.E. Knapen, M. van de Werken, M.C.M. Gordijn, Y. Meesters 
Impact of comprehensive day treatment on societal participation for persons with acquired brain injury  James F. Malec, PhD  Archives of Physical Medicine.
Aggressive Behavior in Patients With Stroke: Association With Psychopathology and Results of Antidepressant Treatment on Aggression  Keen-Loong Chan,
Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction  Steven A. Kaplan,
James H. Liu, MD  The American Journal of Medicine 
Irritability in a mixed sample of patients with unipolar and bipolar II depression predicts responsiveness to lamotrigine  Evyn M. Peters, Rudy Bowen 
Citalopram is less effective for patients with neurological disorder and/or post-traumatic stress disorder  Farrokh Alemi, Aryan Mazloum-Yazdi, Lora Peppard 
Work Ability Index Predicts Application for Disability Pension After Work-Related Medical Rehabilitation for Chronic Back Pain  Matthias Bethge, PhD,
Volume 70, Issue 3, Pages (September 2016)
Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from.
The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study  Hsien-Yi Chiu, MD, Tsen-Fang.
Treatment of notalgia paresthetica with botulinum toxin A: A double-blind randomized controlled trial  Catherine Maari, MD, FRCPC, Philippe Marchessault,
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Acupuncture and trager psychophysical integration in the treatment of wheelchair user's shoulder pain in individuals with spinal cord injury  Trevor A.
Joseph R. Boland, Brenna Duffy, Nicole M. Myer 
Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid- Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched,
K. Richardson, D.Z.H. Levett, S. Jack, M.P.W. Grocott 
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
Calendar Annals of Emergency Medicine
A randomized, double-blind, crossover study of the use of transcutaneous spinal electroanalgesia in patients with pain from chronic critical limb ischemia 
Measurement invariance of the Childhood Trauma Questionnaire by gender, poverty level, and HIV status  Violeta J. Rodriguez, Pablo D. Radusky, Mahendra.
Comparison of the Effectiveness of Amitriptyline and Gabapentin on Chronic Neuropathic Pain in Persons With Spinal Cord Injury  Diana H. Rintala, PhD,
Apathy and depression: Which clinical specificities?
Personalized Medicine in Psychiatry
Reply Journal of Allergy and Clinical Immunology
Adiponectin moderates antidepressant treatment outcome in the combining medications to enhance depression outcomes randomized clinical trial  Jennifer.
Personalized Medicine in Psychiatry
SCL6A4 polymorphisms rs25533 and I425V: Association with obsessive–compulsive disorder and its treatment response in Iranian patients  Ehsan Ahmadipour,
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients  Drucy Borowitz, Christopher Stevens,
Efficacy of Cognitive-Behavioral Therapy for Insomnia Associated With Traumatic Brain Injury: A Single-Case Experimental Design  Marie-Christine Ouellet,
Volume 3, Issue 7, Pages (July 2016)
Christian Stief  European Urology Supplements 
Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD 
Personalized Medicine in Psychiatry
Responses of the Less Affected Arm to Bilateral Upper Limb Task Training in Early Rehabilitation After Stroke: A Randomized Controlled Trial   Jacqui.
Osteoarthritis year 2010 in review: non-pharmacologic therapy
Early decreases in blood eosinophil levels with reslizumab
Jerrilyn A. Cambron, DC, MPH, PhD, Jennifer M
Improving Flexibility and Quality of Life for Your Patients: A Must?
Volume 143, Issue 6, (December 2010)
A Preliminary Assessment of the Benefits of the Addition of Botulinum Toxin A to a Conventional Therapy Program on the Function of People With Longstanding.
An 8-week open label trial of l-Threonic Acid Magnesium Salt in patients with mild to moderate dementia  Tonita E. Wroolie, Kewei Chen, Kathleen T. Watson,
Organization news Archives of Physical Medicine and Rehabilitation
Volume 9, Issue 6, (December 2011)
Reviewer Acknowledgment
Impact of comprehensive day treatment on societal participation for persons with acquired brain injury  James F. Malec, PhD  Archives of Physical Medicine.
Proposal for a surrogate surgical invasiveness score to obtain a ‘post hoc’ quantification of surgical stress and tissue trauma in the context of postoperative.
A Randomized, Double-Blind, Placebo-controlled Study of Growth Hormone in the Treatment of Fibromyalgia 1  Robert M Bennett, Sharon C Clark, Jacqueline.
Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L
Steven P. Broglio, PhD, ATC, Jacob J. Sosnoff, PhD, Karl S
Refining treatment choices for ADHD
Volume 51, Issue 5, Pages (May 2007)
M. Doherty, P. Dieppe  Osteoarthritis and Cartilage 
ACRM News Archives of Physical Medicine and Rehabilitation
Margaret A. Finley, PhD, PT, Mary M. Rodgers, PhD, PT 
Distinguishing Patient Satisfaction With Treatment Delivery From Treatment Effect: A Preliminary Investigation of Patient Satisfaction With Symptoms After.
Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid- Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched,
Presentation transcript:

Early treatment response affects signal detection in a placebo-controlled depression study  Steven D. Targum, Christopher J. Catania  Personalized Medicine in Psychiatry   Volume 4, Pages 19-24 (December 2017) DOI: 10.1016/j.pmip.2017.10.001 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Early QIDS-SR16 improvement and eventual treatment response*. *Early improvement reflects the change of total QIDS-SR16 score between baseline and week 2. QIDs-SR16 treatment response at 6 weeks is defined as ≥50% improvement from baseline. Personalized Medicine in Psychiatry  2017 4, 19-24DOI: (10.1016/j.pmip.2017.10.001) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Impact of early QIDS-SR16 treatment response on eventual treatment outcome. *post-hoc exclusion of 32 subjects with a conventional treatment response (≥50% QIDS-SR16 improvement from baseline) within 2 weeks following randomization (weeks 0–2). Personalized Medicine in Psychiatry  2017 4, 19-24DOI: (10.1016/j.pmip.2017.10.001) Copyright © 2017 The Authors Terms and Conditions